12Jan 2025
EV Monitoring for Treatment Response in NSCLC

EV Monitoring for Treatment Response in NSCLC

This study explored the role of extracellular vesicle (EV) monitoring in assessing treatment response in advanced non-small cell lung cancer (NSCLC). Plasma samples from 27 patients were analyzed for cfEV protein content and size. A ∆cfEV <20% was associated with improved progression-free survival (PFS), especially for patients on pembrolizumab or osimertinib. This method provides valuable insights into treatment efficacy and could complement clinical assessment in NSCLC.

  • #oncology

Like

Save

Share